TapewireFind a company

person · Reporting owner

BROWN JEFFREY J

Disclosed activity across 4 companies

Tapewire entity
31298
SEC CIK
0001245377

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CADIZ INCCDZI · Entity 5819DirectorJanuary 02, 2020January 03, 2020
MEDIFAST INCMED · Entity 6587DirectorJune 25, 2025June 26, 2025
UPBOUND GROUP, INC.UPBD · Entity 599DirectorOctober 01, 2026October 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CADIZ INC

Report date January 02, 2020 · Filed January 03, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect8,868 Reported balance After 2020-01-02 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2020-01-02 · Grant · Acquired 1,133 · Balance 8,868

F1: These shares were allocated to the Reporting Person under the 2019 Equity Incentive Plan in lieu of cash compensation for services rendered by the Reporting Person as a director of the Issuer for the 3-month period beginning January 1, 2020.

F2: Includes 1,914 shares allocated to the Reporting Person under the 2014 Equity Incentive Plan for services rendered by the Reporting Person as a director of the Issuer for the 12-month period ended June 30, 2019, which shares will vest on January 31, 2020.

Filing footnotes · ownership attribution and instrument terms

F1: These shares were allocated to the Reporting Person under the 2019 Equity Incentive Plan in lieu of cash compensation for services rendered by the Reporting Person as a director of the Issuer for the 3-month period beginning January 1, 2020.

F2: Includes 1,914 shares allocated to the Reporting Person under the 2014 Equity Incentive Plan for services rendered by the Reporting Person as a director of the Issuer for the 12-month period ended June 30, 2019, which shares will vest on January 31, 2020.

MEDIFAST INC

Report date June 25, 2025 · Filed June 26, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect38,577.647 Ending reported balance After 2025-06-25 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2025-06-25 · Grant · Acquired 11,167.542 · Balance 29,128.189

F1: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026.

Row 2 · 2025-06-25 · Grant · Acquired 9,449.458 · Balance 38,577.647

F2: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.

F3: The price per share of $13.39 is based on the 20-day moving average stock price of the Issuer's common stock as of June 6, 2025.

Common StockSEC Table I · non-derivativeIndirectJeffrey Brown Living Trust4,232.967 Reported balance Holding disclosure · report date 2025-06-25 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 4,232.967

F4: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.

Filing footnotes · ownership attribution and instrument terms

F1: These restricted stock units were granted under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated (the "Plan"), in connection with the payment of the reporting person's annual director fees. Each unit represents the right to receive one share of the Issuer's common stock. These shares are granted from the Issuer's Amended and Restated 2012 Share Incentive Plan and will vest in full on June 25, 2026.

F2: The reporting person elected, pursuant to the Plan, to receive shares of the Issuer's common stock in lieu of cash compensation of annual service as a non-employee director of the Issuer.

F3: The price per share of $13.39 is based on the 20-day moving average stock price of the Issuer's common stock as of June 6, 2025.

F4: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.

UPBOUND GROUP, INC.

Report date October 01, 2026 · Filed October 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Director Deferred Stock UnitSEC Table II · derivative / convertible securityDirect178,903 Reported balance After 2026-10-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-10-01 · Grant · Acquired 6,220 · Balance 178,903

F1: Each Director Deferred Stock Unit represents the right to receive one share of the common stock, $.01 par value per share, of the issuer ("Common Stock"). The Director Deferred Stock Units are fully vested and non-forfeitable. The Common Stock will be issued to the reporting person upon the termination of their service as a member of the issuer's board of directors.

Filing footnotes · ownership attribution and instrument terms

F1: Each Director Deferred Stock Unit represents the right to receive one share of the common stock, $.01 par value per share, of the issuer ("Common Stock"). The Director Deferred Stock Units are fully vested and non-forfeitable. The Common Stock will be issued to the reporting person upon the termination of their service as a member of the issuer's board of directors.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

OUTERWALL INC

Report date September 23, 2016 · Filed September 27, 2016

Section 16 reporting ended · disclosed 2016-09-27. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Ending reported balance After 2016-09-27 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2016-09-23 · Other · Disposed 234 · Balance 2,601

F1: Pursuant to the terms of the Agreement and Plan of Merger, dated July 24, 2016, by and among Outerwall Inc. ("Issuer"), Aspen Parent, Inc., Aspen Merger Sub, Inc., Redwood Merger Sub, Inc. and Redbox Automated Retail, LLC (the "Merger Agreement"), on August 5, 2016, Aspen Merger Sub, Inc. made an offer (the "Offer") to purchase each outstanding share of the Issuer's common stock for $52.00 per share, in cash, without interest (the "Merger Consideration"). The shares shown on this line were tendered in the Offer.

F2: Pursuant the Merger Agreement, each outstanding share of common stock of Issuer at the Effective Time (as defined in the Merger Agreement) was converted into the right to receive the Merger Consideration.

Row 2 · 2016-09-27 · Other · Disposed 2,601 · Balance 0

F2: Pursuant the Merger Agreement, each outstanding share of common stock of Issuer at the Effective Time (as defined in the Merger Agreement) was converted into the right to receive the Merger Consideration.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms of the Agreement and Plan of Merger, dated July 24, 2016, by and among Outerwall Inc. ("Issuer"), Aspen Parent, Inc., Aspen Merger Sub, Inc., Redwood Merger Sub, Inc. and Redbox Automated Retail, LLC (the "Merger Agreement"), on August 5, 2016, Aspen Merger Sub, Inc. made an offer (the "Offer") to purchase each outstanding share of the Issuer's common stock for $52.00 per share, in cash, without interest (the "Merger Consideration"). The shares shown on this line were tendered in the Offer.

F2: Pursuant the Merger Agreement, each outstanding share of common stock of Issuer at the Effective Time (as defined in the Merger Agreement) was converted into the right to receive the Merger Consideration.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 07, 2019 Filed Feb 11, 2019 20:23 UTC MEDIFAST INC MED · Entity 6587 Exercise / conversionStock Options · Derivative 1,667 $0.00 Strike: $27.68 $0.00
Disclosure

SEC source: 0001144204-19-006227 · tv513081_4.xml · derivative · entry 2

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,667 shares

Expires 2026-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options vested in three equal annual installments beginning February 4, 2017.

Read SEC document
February 07, 2019 Filed Feb 11, 2019 20:23 UTC MEDIFAST INC MED · Entity 6587 Exercise / conversionCommon Stock 1,667 $27.68 $46,142.56
Disclosure

SEC source: 0001144204-19-006227 · tv513081_4.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,635

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 05, 2019 Filed May 8, 2020 23:02 UTC MEDIFAST INC MED · Entity 6587 PurchaseCommon Stock 59.161 $129.49 $7,660.76
Disclosure

SEC source: 0001104659-20-058952 · tm2019159d1_4.xml · nonDerivative · entry 6

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 10,273.161

F1 · ownership.nature: The shares were acquired by Brown Equity Partners, LLC ("BEP"), for which the reporting person is the managing member.

Read SEC document
January 02, 2019 Filed Jan 3, 2019 21:15 UTC CADIZ INC CDZI · Entity 5819 GrantCommon Stock 728 $10.30 $7,498.40
Disclosure

SEC source: 0001189957-19-000003 · primary_doc.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,935

F1 · shares: These shares were allocated to the Reporting Person under the 2014 Equity Incentive Plan in lieu of cash compensation for services rendered by the Reporting Person as a director of the Issuer for the 3-month period beginning January 1, 2019.

F2 · balance_after: Includes 393 shares allocated to the Reporting Person under the 2014 Equity Incentive Plan for services rendered by the Reporting Person as a director of the Issuer for the 3-month period ended June 30, 2018, which shares vest on January 31, 2019.

Read SEC document
November 29, 2018 Filed Dec 4, 2018 17:39 UTC MEDIFAST INC MED · Entity 6587 Exercise / conversionStock Options · Derivative 3,333 $0.00 Strike: $27.68 $0.00
Disclosure

SEC source: 0001144204-18-063038 · tv508294_form4.xml · derivative · entry 4

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,667

Underlying: Common Stock · 3,333 shares

Expires 2026-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options vest in three equal annual installments beginning February 4, 2017

Read SEC document
November 29, 2018 Filed Dec 4, 2018 17:39 UTC MEDIFAST INC MED · Entity 6587 Exercise / conversionStock Options · Derivative 2,500 $0.00 Strike: $28.59 $0.00
Disclosure

SEC source: 0001144204-18-063038 · tv508294_form4.xml · derivative · entry 3

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2025-09-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options vested in three equal annual installments beginning February 17, 2016

Read SEC document
November 29, 2018 Filed Dec 4, 2018 17:39 UTC MEDIFAST INC MED · Entity 6587 Exercise / conversionCommon Stock 3,333 $27.68 $92,257.44
Disclosure

SEC source: 0001144204-18-063038 · tv508294_form4.xml · nonDerivative · entry 2

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,968

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 29, 2018 Filed Dec 4, 2018 17:39 UTC MEDIFAST INC MED · Entity 6587 Exercise / conversionCommon Stock 2,500 $28.59 $71,475.00
Disclosure

SEC source: 0001144204-18-063038 · tv508294_form4.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,635

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 08, 2018 Filed May 8, 2020 23:02 UTC MEDIFAST INC MED · Entity 6587 PurchaseCommon Stock 30.291 $157.00 $4,755.69
Disclosure

SEC source: 0001104659-20-058952 · tm2019159d1_4.xml · nonDerivative · entry 5

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 10,214

F1 · ownership.nature: The shares were acquired by Brown Equity Partners, LLC ("BEP"), for which the reporting person is the managing member.

Read SEC document
October 03, 2018 Filed Oct 5, 2018 17:14 UTC CADIZ INC CDZI · Entity 5819 GrantCommon Stock 676 $11.10 $7,503.60
Disclosure

SEC source: 0000923876-18-000001 · primary_doc.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,207

F1 · shares: These shares were allocated to the Reporting Person under the 2015 Equity Incentive Plan in lieu of cash compensation for services rendered by the Reporting Person as a director of the Issuer for the 3-month period beginning October 1, 2018.

F2 · balance_after: Includes 393 shares allocated to the Reporting Person under the 2014 Equity Incentive Plan for services rendered by the Reporting Person as a director of the Issuer for the 3-month period ended June 30, 2018, which shares vest on January 31, 2019.

Read SEC document
August 08, 2018 Filed May 8, 2020 23:02 UTC MEDIFAST INC MED · Entity 6587 PurchaseCommon Stock 24.44 $199.53 $4,876.51
Disclosure

SEC source: 0001104659-20-058952 · tm2019159d1_4.xml · nonDerivative · entry 4

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 10,183.709

F1 · ownership.nature: The shares were acquired by Brown Equity Partners, LLC ("BEP"), for which the reporting person is the managing member.

Read SEC document
July 01, 2018 Filed Jul 2, 2018 22:10 UTC CADIZ INC CDZI · Entity 5819 GrantCommon Stock 574 $13.08 $7,505.05
Disclosure

SEC source: 0001189957-18-000007 · primary_doc.xml · nonDerivative · entry 2

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,531

F1 · shares: These shares were allocated to the Reporting Person under the 2014 Equity Incentive Plan in lieu of cash compensation for services rendered by the Reporting Person as a director of the Issuer for the 3-month period beginning July 1, 2018.

F2 · balance_after: Includes 393 shares allocated to the Report Person under the 2014 Equity Incentive Plan for services rendered by the Reporting Person as a director of the Issuer for the 3-month period ended June 30, 2018, which shares will vest on January 31, 2019.

Read SEC document
June 30, 2018 Filed Jul 2, 2018 22:10 UTC CADIZ INC CDZI · Entity 5819 GrantCommon Stock 393 $12.71 $4,995.03
Disclosure

SEC source: 0001189957-18-000007 · primary_doc.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 957

Read SEC document
June 13, 2018 Filed Jun 15, 2018 19:37 UTC CADIZ INC CDZI · Entity 5819 GrantCommon Stock 564 $13.30 $7,501.20
Disclosure

SEC source: 0001408441-18-000004 · primary_doc.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 564

F1 · shares: These shares were allocated to the Reporting Person under the 2014 Equity Incentive Plan in lieu of cash compensation for services rendered by the Reporting Person as a director of the Issuer for the 3-month period beginning April 1, 2018.

Read SEC document
May 08, 2018 Filed May 8, 2020 23:02 UTC MEDIFAST INC MED · Entity 6587 PurchaseCommon Stock 41.712 $116.43 $4,856.53
Disclosure

SEC source: 0001104659-20-058952 · tm2019159d1_4.xml · nonDerivative · entry 3

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 10,159.269

F1 · ownership.nature: The shares were acquired by Brown Equity Partners, LLC ("BEP"), for which the reporting person is the managing member.

Read SEC document
February 08, 2018 Filed May 8, 2020 23:02 UTC MEDIFAST INC MED · Entity 6587 PurchaseCommon Stock 72.068 $66.91 $4,822.07
Disclosure

SEC source: 0001104659-20-058952 · tm2019159d1_4.xml · nonDerivative · entry 2

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 10,117.557

F1 · ownership.nature: The shares were acquired by Brown Equity Partners, LLC ("BEP"), for which the reporting person is the managing member.

Read SEC document
February 07, 2018 Filed Feb 9, 2018 23:21 UTC MEDIFAST INC MED · Entity 6587 GrantCommon Stock 1,860 $0.00 $0.00
Disclosure

SEC source: 0001144204-18-007040 · tv485449_form4.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,135

F1 · shares: This annual restricted stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest in full on June 30, 2019.

Read SEC document
January 02, 2018 Filed Jan 4, 2018 20:00 UTC UPBOUND GROUP, INC. RCII · Entity 599 GrantDirector Deferred Stock Unit · Derivative 14,265 Not disclosed Not disclosed
Disclosure

SEC source: 0001225208-18-000606 · doc4.xml · derivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,265

Underlying: Common · 14,265 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Director Deferred Stock Unit represents the right to receive one share of the common stock, $.01 par value per share, of the issuer ("Common Stock"). The Director Deferred Stock Units are fully vested and non-forfeitable. The Common Stock will be issued to the reporting person upon the termination of his service as a member of the issuer's board of directors.

F1 · price: Each Director Deferred Stock Unit represents the right to receive one share of the common stock, $.01 par value per share, of the issuer ("Common Stock"). The Director Deferred Stock Units are fully vested and non-forfeitable. The Common Stock will be issued to the reporting person upon the termination of his service as a member of the issuer's board of directors.

F1 · derivative.exercise_date: Each Director Deferred Stock Unit represents the right to receive one share of the common stock, $.01 par value per share, of the issuer ("Common Stock"). The Director Deferred Stock Units are fully vested and non-forfeitable. The Common Stock will be issued to the reporting person upon the termination of his service as a member of the issuer's board of directors.

F1 · derivative.expiration_date: Each Director Deferred Stock Unit represents the right to receive one share of the common stock, $.01 par value per share, of the issuer ("Common Stock"). The Director Deferred Stock Units are fully vested and non-forfeitable. The Common Stock will be issued to the reporting person upon the termination of his service as a member of the issuer's board of directors.

Read SEC document
November 09, 2017 Filed May 8, 2020 23:02 UTC MEDIFAST INC MED · Entity 6587 PurchaseCommon Stock 45.489 $70.35 $3,200.15
Disclosure

SEC source: 0001104659-20-058952 · tm2019159d1_4.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 10,045.489

F1 · ownership.nature: The shares were acquired by Brown Equity Partners, LLC ("BEP"), for which the reporting person is the managing member.

Read SEC document
February 16, 2017 Filed Feb 22, 2017 00:57 UTC MEDIFAST INC MED · Entity 6587 GrantCommon Stock 3,021 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-010266 · v460104_4.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,275

F1 · shares: This annual restricted stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest in full on June 30, 2018.

Read SEC document
November 09, 2016 Filed Nov 14, 2016 21:12 UTC MEDIFAST INC MED · Entity 6587 PurchaseCommon Stock 10,000 $38.71 $387,100.00
Disclosure

SEC source: 0001144204-16-134188 · v452918_4.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,254

F1 · shares: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.29 to $38.90. The reporting person agrees to provide upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
November 09, 2016 Filed Mar 1, 2019 22:03 UTC Amendment MEDIFAST INC MED · Entity 6587 PurchaseCommon Stock 10,000 $38.71 $387,100.00
Disclosure

SEC source: 0001144204-19-011668 · tv515216_4a.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 10,000

F1 · shares: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.29 to $38.90. The reporting person agrees to provide upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range.

F2 · ownership.nature: The original Form 4 erroneously reported that the reporting person acquired these shares directly. However, the shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member. The reporting person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.

Read SEC document
September 27, 2016 Filed Sep 27, 2016 18:06 UTC OUTERWALL INC OUTR · Entity 182080 OtherCommon Stock 2,601 $52.00 $135,252.00
Disclosure

SEC source: 0000899243-16-030164 · doc4.xml · nonDerivative · entry 2

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · kind: Pursuant the Merger Agreement, each outstanding share of common stock of Issuer at the Effective Time (as defined in the Merger Agreement) was converted into the right to receive the Merger Consideration.

Read SEC document
September 23, 2016 Filed Sep 27, 2016 18:06 UTC OUTERWALL INC OUTR · Entity 182080 OtherCommon Stock 234 $52.00 $12,168.00
Disclosure

SEC source: 0000899243-16-030164 · doc4.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,601

F1 · kind: Pursuant to the terms of the Agreement and Plan of Merger, dated July 24, 2016, by and among Outerwall Inc. ("Issuer"), Aspen Parent, Inc., Aspen Merger Sub, Inc., Redwood Merger Sub, Inc. and Redbox Automated Retail, LLC (the "Merger Agreement"), on August 5, 2016, Aspen Merger Sub, Inc. made an offer (the "Offer") to purchase each outstanding share of the Issuer's common stock for $52.00 per share, in cash, without interest (the "Merger Consideration"). The shares shown on this line were tendered in the Offer.

F2 · kind: Pursuant the Merger Agreement, each outstanding share of common stock of Issuer at the Effective Time (as defined in the Merger Agreement) was converted into the right to receive the Merger Consideration.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.